Gate2Brain

About Gate2Brain

Gate2Brain is a biotech company focused on developing therapeutics that efficiently cross biological barriers, such as the blood-brain barrier. The company uses a patented peptide-based technology platform to improve delivery of cargoes including small molecules, peptides, nanoparticles, proteins and antibodies, enabling treatments for diseases where barrier penetration is a limiting factor. Its research and development emphasis includes pediatric cancer and other conditions impacted by limited drug delivery to the brain and other tissues. Headquartered in Barcelona, Spain, Gate2Brain aims to advance medicines beyond barriers to reach patients who need them most.